Elevated plasma alpha1-acid glycoprotein levels: Lack of connection to resistance to vecuronium blockade induced by anticonvulsant therapy

Journal of Neurosurgical Anesthesiology

Volumn 9, Issue 1, 1997, Pages 3-7

  Hans, P ^a   Brichant, J F ^a   Pieron, F ^a   Pieyns, P ^a   Born, J D ^a   Lamy, M ^a  

^a Centre Hospitalier Regional de La Citadelle   (Belgium)

Author keywords

Alpha1 acid glycoprotein; Anticonvulsants; Drug interactions; Muscle relaxants; Vecuronium

Indexed keywords

ANESTHETIC AGENT; ANTICONVULSIVE AGENT; CARBAMAZEPINE; OROSOMUCOID; PHENOBARBITAL; PHENYTOIN; PROPOFOL; SUFENTANIL; VECURONIUM;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG PROTEIN BINDING; HUMAN; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR TRANSMISSION; NEUROSURGERY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEIZURE;

EID: 0031028259     PISSN: 08984921     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008506-199701000-00003     Document Type: Article

References (13)

1. Messick JM, Maass L, Faust RJ, Cucchiara RF. Duration of pancuronium blockade in patients taking anticonvulsant medication. Anesth Annlg 1982;61:203-4.
2. Ornstein E, Matteo RS, Silverberg PA, Schwartz AE, Young WL, Diaz J. Chronic phenytoin therapy and nondepolarizing muscular blockade. Anesthesiology 1985;63: A331.
3. Ornstein E, Matteo RS, Schwartz AE, Silverberg PA, Young WL, Diaz J. The effect of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium. Anesthesiology 1987;67:191-6.
4. Tempelhoff R, Modica PA, Jellish WS, Spitznragel EL. Resistance to atracurium-induced neuromuscular blockade in patients with intractable seizure disorders treated with anticonvulsants. Anesth Analg 1990;71:665-9.
5. Platt PR, Thackray NM. Phenytoin-induced resistance to vecuronium. Anaesth Intens Care 1993;21:185-91.
6. Martyn JAJ, White SA, Gronert GA, Jaffe RS, Ward JM. Up-and-down regulation of skeletal muscle acetylcholine receptors: effects on neuromuscular blockers. Anesthesiology 1992;76:822-43.
7. Garcia E, Calvo R, Rodiguez-Sasian M, Jimenez I, Troconiz F, Suarez E. Resistance to atracurium in rats with experimental inflammation: role of protein binding. Acta Anaesthesiol Scand 1995;39:1019-23.
8. Kim CS, Arnold FJ, Itani MS, Martyn JAJ. Decreased sensitivity to metocurine during long-term phenytoin therapy may be attributable to protein binding and acetylcholine receptor changes. Anesthesiology 1992;77:500-6.
9. Hans P, Ledoux D, Bonhomme V, Brichant JF. Effect of plasma anticonvulsant level on pipecuronium induced neuromuscular blockade: preliminary results. J Neurosurg Anesthesiol 1995;7:254-8.
10. 1-acid glycoprotein and antipyrine clearance in the dog. Eur J Drug Metab Pharmacokinet 1986;11: 135-43.
11. Duvaldestin P, Henzel D. Binding of tubocurarine, fazadinium, pancuronium and ORG NC45 serum proteins in normal man and in patients with cirrhosis. Br J Anaesth 1982;54: 513-6.
12. Foldes FF, Deery A. Protein binding of atracurium and other short-acting neuromuscular blocking agents and their interaction with human cholinesterases. Br J Anaesth 1983;55: 31S-4S.
13. Yanez P, Martyn JAJ. Prolonged d-tubocurarine infusion and/or immobilization cause upregulation of acetylcholine receptors and hyperkalemia to succinylcholine in rats. Anesthesiology 1996;84:384-91.